InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 9, 2022
InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV May 5, 2022
InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading… Apr 28, 2022
InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Apr 21, 2022
InMed Pharmaceuticals Strengthens Its Commercial Leadership Team With The Appointment Of Vice President Of Sales And… Feb 15, 2022
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Jan 19, 2022
InMed’s Year-End Correspondence To Shareholders Focuses On Its Accomplishments And A Bullish Future Jan 6, 2022
